OMass Therapeutics

Jnana Therapeutics

This clinical-stage biotechnology company develops small molecule medicines for patients with rare and immune-mediated diseases using a proprietary chemoproteomics drug discovery platform.

Orogen Therapeutics

Orogen Therapeutics develops small-molecule drugs for autoimmune and immuno-inflammatory diseases using an AI-enabled DNA-encoded library platform to identify novel chemical matter for patients.

Odyssey Therapeutics

This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.

Matchpoint Therapeutics

This biotechnology company develops oral covalent small molecule medicines to treat patients with autoimmune and inflammatory diseases.

Sitryx Therapeutics

The company develops oral small molecule therapies to treat patients with autoimmune and inflammatory diseases by regulating immune cell metabolism.

Forward Therapeutics

The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.

Sitryx

This biopharmaceutical company develops oral small molecule medicines that target immune cell metabolism to treat patients with chronic autoimmune and inflammatory diseases.

Kymera Therapeutics

This biotechnology company develops small molecule medicines that degrade disease-causing proteins for patients with cancer and immune-inflammatory diseases.